Buying $100 In GILD: If an investor had bought $100 of GILD stock 20 years ago, it would be worth $1,201.60 today based on a ...
Gilead (GILD) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
The stock's fall snapped a two-day winning streak.
The HIV and hepatitis C drugmaker's stock has climbed by 3.63% in the ... Investors will be eagerly watching for the performance of Gilead Sciences in its upcoming earnings disclosure.
In the assessment of 12-month price targets, analysts unveil insights for Gilead Sciences, presenting an average target of ...
Bernstein analyst Courtney Breen maintained a Buy rating on Gilead Sciences (GILD – Research Report) yesterday and set a price target of ...
Gilead Sciences Inc. closed 3.35% below its 52-week high of $98.90, which the company achieved on November 11th.